Sandbox:hudakarman: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) No edit summary |
Hudakarman (talk | contribs) No edit summary |
||
| Line 199: | Line 199: | ||
<nowiki>{{SK}}</nowiki> <ref name="pmid19754615">{{cite journal| author=Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ| title=Type 2 diabetes in children and adolescents. | journal=Pediatr Diabetes | year= 2009 | volume= 10 Suppl 12 | issue= | pages= 17-32 | pmid=19754615 | doi=10.1111/j.1399-5448.2009.00584.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19754615 }}</ref> | <nowiki>{{SK}}</nowiki> <ref name="pmid19754615">{{cite journal| author=Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ| title=Type 2 diabetes in children and adolescents. | journal=Pediatr Diabetes | year= 2009 | volume= 10 Suppl 12 | issue= | pages= 17-32 | pmid=19754615 | doi=10.1111/j.1399-5448.2009.00584.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19754615 }}</ref> | ||
==Table1== | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | {| style="border: 0px; font-size: 90%; margin: 3px;" align=center | ||
| Line 228: | Line 230: | ||
|} | |} | ||
==Table2== | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | {| style="border: 0px; font-size: 90%; margin: 3px;" align=center | ||
| Line 246: | Line 248: | ||
==Table3== | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | ||
| Line 278: | Line 280: | ||
|} | |} | ||
==Table4== | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | {| style="border: 0px; font-size: 90%; margin: 3px;" align=center | ||
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF| Disease}} | ! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF| Disease}} | ||
Revision as of 17:58, 4 June 2020
Template:A Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Huda A. Karman, M.D.
|
Disease Microchapters |
|
Treatment |
|---|
|
Case Studies |
.................................. ................................ ......................................
{{SK}} [1]
Table1
| Variant | Associated mutation |
|---|---|
Table2
| Variant | Associated mutation |
|---|---|
Table3
| A | B |
|---|---|
| C |
|
| E | F |
| |
| H | |
| |
| K | |
| |
| M | |
|
Table4
| Disease | Characteristics | Signs and Symptoms | Associated Conditions | Histopathology | Lab finding
& Other evaluation |
Prognosis |
|---|---|---|---|---|---|---|
| A |
|
|
|
|
|
|
CVS
CVS
vsd
ASD
Synonyms and keywords:
HEM has four main components, Preparedness, response, recovery, and mitigation. When we assess the development, the challenges, the setbacks, and progress of FEMA throughout history, we should look at the big picture and and also at the individual components. 1903:
References
- ↑ Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith GJ (2009). "Type 2 diabetes in children and adolescents". Pediatr Diabetes. 10 Suppl 12: 17–32. doi:10.1111/j.1399-5448.2009.00584.x. PMID 19754615.